talazoparib,atezolizumab
pfizer,roche
['atezo', 'talazo', 'biomarker', 'sclc']
#asco23 #sclc trial of atezo +| - talazoparib in #sclc maintenance in #slfn11 positive pts mpfs improved this demonstrates that biomarker driven studies are feasible fantastic job 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl